These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 25258684)
21. Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer. Cho Y; Kim JW; Chang JS; Kim JY; Ahn SG; Bae SJ; Jeong J; Lee IJ Front Oncol; 2023; 13():1182820. PubMed ID: 37213308 [TBL] [Abstract][Full Text] [Related]
22. [Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), Mailand]. Gatzemeier W; Orecchia R; Gatti G; Intra M; Veronesi U Strahlenther Onkol; 2001 Jul; 177(7):330-7. PubMed ID: 11505618 [TBL] [Abstract][Full Text] [Related]
23. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294 [TBL] [Abstract][Full Text] [Related]
24. Comparison of seroma production in breast conserving surgery with or without intraoperative radiotherapy as tumour bed boost. Ebner F; Schramm A; Bottke D; Friedl TW; Wiegel T; Fink V; Lato K; Bekes I; Janni W; de Gregorio N Arch Gynecol Obstet; 2016 Oct; 294(4):861-6. PubMed ID: 27256339 [TBL] [Abstract][Full Text] [Related]
25. Intraoperative Radiotherapy for Breast Cancer. Harris EER; Small W Front Oncol; 2017; 7():317. PubMed ID: 29312887 [TBL] [Abstract][Full Text] [Related]
26. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer. Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952 [TBL] [Abstract][Full Text] [Related]
27. Intraoperative Boost Radiotherapy during Targeted Oncoplastic Breast Surgery: Overview and Single Center Experiences. Malter W; Kirn V; Richters L; Fridrich C; Markiefka B; Bongartz R; Semrau R; Mallmann P; Kraemer S Int J Breast Cancer; 2014; 2014():637898. PubMed ID: 25587453 [TBL] [Abstract][Full Text] [Related]
28. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity. Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267 [TBL] [Abstract][Full Text] [Related]
29. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results. Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241 [TBL] [Abstract][Full Text] [Related]
30. Prospective study of local control and late radiation toxicity after intraoperative radiation therapy boost for early breast cancer. Chang DW; te Marvelde L; Chua BH Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):73-9. PubMed ID: 24331652 [TBL] [Abstract][Full Text] [Related]
31. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon. Rajan SS; Sharma SC; Kumar N; Kumar R; Singh G; Singh R; Tomar P J Cancer Res Ther; 2014; 10(4):889-95. PubMed ID: 25579524 [TBL] [Abstract][Full Text] [Related]
32. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH; Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696 [TBL] [Abstract][Full Text] [Related]
33. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial). Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Saunders C; Brew-Graves C; Potyka I; Morris S; Vaidya HJ; Williams NR; Baum M Health Technol Assess; 2016 Sep; 20(73):1-188. PubMed ID: 27689969 [TBL] [Abstract][Full Text] [Related]
34. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843 [TBL] [Abstract][Full Text] [Related]
36. Evaluating radiotherapy options in breast cancer: does intraoperative radiotherapy represent the most cost-efficacious option? Shah C; Badiyan S; Khwaja S; Shah H; Chitalia A; Nanavati A; Kundu N; Vaka V; Lanni TB; Vicini FA Clin Breast Cancer; 2014 Apr; 14(2):141-6. PubMed ID: 24291378 [TBL] [Abstract][Full Text] [Related]
37. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Veronesi U; Orecchia R; Luini A; Gatti G; Intra M; Zurrida S; Ivaldi G; Tosi G; Ciocca M; Tosoni A; De Lucia F Eur J Cancer; 2001 Nov; 37(17):2178-83. PubMed ID: 11677104 [TBL] [Abstract][Full Text] [Related]
38. Radiobiological comparison of hypofractionated accelerated partial-breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV X-rays. Herskind C; Wenz F Strahlenther Onkol; 2010 Aug; 186(8):444-51. PubMed ID: 20803285 [TBL] [Abstract][Full Text] [Related]
39. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach. Wenz F; Welzel G; Blank E; Hermann B; Steil V; Sütterlin M; Kraus-Tiefenbacher U Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1309-14. PubMed ID: 20100643 [TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer. Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]